• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    4/20/22 12:14:38 PM ET
    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACLX alert in real time by email

     

    On Wednesday, 160 companies hit new 52-week lows.

    Areas of Significance In Today's 52-Week Lows:

    • Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new 52-week low.
    • Vallon Pharmaceuticals (NASDAQ:VLON) is the smallest company on a market cap basis to set a new 52-week low.
    • Netflix (NASDAQ:NFLX)'s stock came under the most pressure, trading down 36.5% to reach a new 52-week low.
    • Oncorus (NASDAQ:ONCR) shares bounced back the most, actually rising 0.07% after hiting a new 52-week low.

    The following stocks set new 52-week lows on Wednesday:

    • Walt Disney (NYSE:DIS) stock dropped to a yearly low on Wednesday of $124.65. Shares traded down 4.5%.
    • Netflix (NASDAQ:NFLX) shares hit a yearly low of $212.51. The stock was down 36.5% on the session.
    • Pinterest (NYSE:PINS) stock hit a new 52-week low of $21.20. The stock was down 4.93% on the session.
    • Etsy (NASDAQ:ETSY) stock dropped to a yearly low on Wednesday of $105.75. Shares traded down 7.72%.
    • IAC/InterActive (NASDAQ:IAC) stock set a new 52-week low of $93.50 on Wednesday, moving down 2.74%.
    • Carvana (NYSE:CVNA) shares made a new 52-week low of $92.89 on Wednesday. The stock was down 7.84% for the day.
    • SoFi Technologies (NASDAQ:SOFI) shares hit a yearly low of $6.93. The stock was down 6.01% on the session.
    • Grupo Aval Acciones (NYSE:AVAL) shares were down 0.25% for the day, having made a 52-week low of $4.21.
    • Innovative Industrial (NYSE:IIPR) stock broke to a new 52-week low of $162.44 on Wednesday. Shares of the company traded up 0.78%.
    • ironSource (NYSE:IS) shares were down 4.0% for the day, having made a 52-week low of $4.37.
    • Intellia Therapeutics (NASDAQ:NTLA) stock hit $55.06 on Wednesday morning, setting a new 52-week low for a change of down 1.91%.
    • Denali Therapeutics (NASDAQ:DNLI) shares set a new yearly low of $27.78 this morning. The stock was down 0.46% on the session.
    • Beam Therapeutics (NASDAQ:BEAM) shares moved down 2.77% on Wednesday to hit a new 52-week low of $42.55, drifting down 2.77%.
    • Roivant Sciences (NASDAQ:ROIV) shares hit a yearly low of $3.72. The stock was down 4.28% on the session.
    • Duck Creek Technologies (NASDAQ:DCT) shares set a new yearly low of $17.17 this morning. The stock was down 3.24% on the session.
    • Pacific Biosciences (NASDAQ:PACB) shares set a new 52-week low of $7.01. The stock traded down 3.63%.
    • iRobot (NASDAQ:IRBT) stock hit a yearly low of $50.91. The stock was down 0.32% for the day.
    • Morphic Holding (NASDAQ:MORF) shares were down 4.99% for the day, having made a 52-week low of $33.77.
    • Rocket Companies (NYSE:RKT) stock hit $9.13 on Wednesday morning, setting a new 52-week low for a change of up 1.95%.
    • Starry Group Holdings (NYSE:STRY) stock hit a new 52-week low of $6.14. The stock was up 0.76% on the session.
    • Velo3D (NYSE:VLD) stock hit $4.69 on Wednesday morning, setting a new 52-week low for a change of up 0.73%.
    • Coherus BioSciences (NASDAQ:CHRS) stock achieved a new 52-week low on Wednesday morning, hitting $10.06 and moving down 2.89%.
    • National Energy Services (NASDAQ:NESR) shares set a new yearly low of $7.95 this morning. The stock was down 0.98% on the session.
    • Blackrock Muniholdings (NYSE:MHD) stock broke to a new 52-week low of $13.07 on Wednesday. Shares of the company traded down 0.3%.
    • Excelerate Energy (NYSE:EE) shares set a new yearly low of $25.59 this morning. The stock was down 1.79% on the session.
    • Invesco Mortgage Capital (NYSE:IVR) stock set a new 52-week low of $1.80 on Wednesday, moving up 2.75%.
    • Orchid Island Cap (NYSE:ORC) shares moved up 2.05% on Wednesday to hit a new 52-week low of $2.86, drifting up 2.05%.
    • Swvl Hldgs (NASDAQ:SWVL) stock hit $4.17 on Wednesday morning, setting a new 52-week low for a change of up 2.82%.
    • Porch Group (NASDAQ:PRCH) stock set a new 52-week low of $4.83 on Wednesday, moving down 4.62%.
    • Arcellx (NASDAQ:ACLX) shares reached a new 52-week low of $12.00 on Wednesday morning, moving down 4.6%.
    • Volta (NYSE:VLTA) shares set a new 52-week low of $2.44. The stock traded down 8.52%.
    • Ideanomics (NASDAQ:IDEX) shares set a new 52-week low of $0.80. The stock traded down 1.76%.
    • Meta Materials (NASDAQ:MMAT) stock hit $1.37 on Wednesday morning, setting a new 52-week low for a change of down 2.97%.
    • Tyra Biosciences (NASDAQ:TYRA) shares hit a yearly low of $8.75. The stock was up 0.32% on the session.
    • Revlon (NYSE:REV) stock hit $7.10 on Wednesday morning, setting a new 52-week low for a change of down 4.28%.
    • Praxis Precision Medicine (NASDAQ:PRAX) shares hit a yearly low of $7.90. The stock was down 0.97% on the session.
    • Nuveen New York Quality (NYSE:NAN) stock hit a yearly low of $11.58. The stock was up 0.6% for the day.
    • AFC Gamma (NASDAQ:AFCG) shares set a new yearly low of $17.79 this morning. The stock was up 0.39% on the session.
    • SelectQuote (NYSE:SLQT) stock broke to a new 52-week low of $1.96 on Wednesday. Shares of the company traded down 2.63%.
    • Precigen (NASDAQ:PGEN) shares set a new yearly low of $1.58 this morning. The stock was down 1.23% on the session.
    • Blackrock Municipal (NYSE:BYM) stock broke to a new 52-week low of $12.45 on Wednesday. Shares of the company traded up 0.88%.
    • FTC Solar (NASDAQ:FTCI) shares hit a yearly low of $3.23. The stock was down 5.69% on the session.
    • Blackrock Income Trust (NYSE:BKT) shares set a new yearly low of $4.87 this morning. The stock was down 0.31% on the session.
    • MFS Charter Income (NYSE:MCR) stock hit $6.84 on Wednesday morning, setting a new 52-week low for a change of up 0.15%.
    • Ocular Therapeutix (NASDAQ:OCUL) stock hit $3.90 on Wednesday morning, setting a new 52-week low for a change of down 0.53%.
    • Omeros (NASDAQ:OMER) shares fell to $4.35 on Wednesday, setting a new 52-week low with a shift of down 7.45%.
    • Nkarta (NASDAQ:NKTX) stock hit $8.00 on Wednesday morning, setting a new 52-week low for a change of down 4.03%.
    • Western Asset Inflation (NYSE:WIA) stock hit $11.12 on Wednesday morning, setting a new 52-week low for a change of up 0.18%.
    • Allakos (NASDAQ:ALLK) stock set a new 52-week low of $4.57 on Wednesday, moving down 0.83%.
    • Vroom (NASDAQ:VRM) shares hit a yearly low of $1.80. The stock was down 8.12% on the session.
    • Oramed Pharmaceuticals (NASDAQ:ORMP) shares moved down 4.3% on Wednesday to hit a new 52-week low of $6.24, drifting down 4.3%.
    • Gritstone Bio (NASDAQ:GRTS) stock set a new 52-week low of $3.22 on Wednesday, moving down 2.65%.
    • Omega Therapeutics (NASDAQ:OMGA) shares set a new 52-week low of $4.92. The stock traded down 3.13%.
    • eHealth (NASDAQ:EHTH) stock set a new 52-week low of $8.47 on Wednesday, moving down 4.01%.
    • Neuberger Berman (AMEX:NBH) shares fell to $12.05 on Wednesday, setting a new 52-week low with a shift of up 0.39%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) stock drifted down 1.12% on Wednesday morning to hit a new 52-week low of $6.82.
    • Pioneer Municipal High IT (NYSE:MHI) stock broke to a new 52-week low of $9.63 on Wednesday. Shares of the company traded up 0.72%.
    • Compugen (NASDAQ:CGEN) shares hit a yearly low of $2.52. The stock was down 3.07% on the session.
    • Citizens (NYSE:CIA) stock set a new 52-week low of $3.88 on Wednesday, moving down 1.39%.
    • Bit Digital (NASDAQ:BTBT) stock drifted down 5.66% on Wednesday morning to hit a new 52-week low of $2.58.
    • Applied Molecular (NASDAQ:AMTI) shares hit a yearly low of $4.85. The stock was down 4.32% on the session.
    • American Superconductor (NASDAQ:AMSC) stock achieved a new 52-week low on Wednesday morning, hitting $6.55 and moving down 3.67%.
    • BIT Mining (NYSE:BTCM) shares made a new 52-week low of $2.27 on Wednesday. The stock was down 4.96% for the day.
    • Kopin (NASDAQ:KOPN) stock drifted down 0.28% on Wednesday morning to hit a new 52-week low of $1.73.
    • GTY Technology Holdings (NASDAQ:GTYH) shares reached a new 52-week low of $2.75 on Wednesday morning, moving down 7.67%.
    • Telesat (NASDAQ:TSAT) shares moved down 0.68% on Wednesday to hit a new 52-week low of $12.81, drifting down 0.68%.
    • Romeo Power (NYSE:RMO) stock dropped to a yearly low on Wednesday of $1.13. Shares traded down 1.54%.
    • Finance of America (NYSE:FOA) stock hit $2.43 on Wednesday morning, setting a new 52-week low for a change of up 0.2%.
    • Rubius Therapeutics (NASDAQ:RUBY) stock hit a yearly low of $1.53. The stock was down 0.94% for the day.
    • CytomX Therapeutics (NASDAQ:CTMX) stock hit a new 52-week low of $2.12. The stock was down 1.13% on the session.
    • Passage Bio (NASDAQ:PASG) stock hit a new 52-week low of $2.52. The stock was down 1.15% on the session.
    • First Eagle Alternative (NASDAQ:FCRD) stock achieved a new 52-week low on Wednesday morning, hitting $4.07 and moving down 2.85%.
    • Molecular Templates (NASDAQ:MTEM) shares set a new 52-week low of $2.12. The stock traded down 4.42%.
    • Biomea Fusion (NASDAQ:BMEA) stock broke to a new 52-week low of $4.01 on Wednesday. Shares of the company traded down 2.88%.
    • Ellington Residential (NYSE:EARN) stock hit $8.63 on Wednesday morning, setting a new 52-week low for a change of up 2.29%.
    • Homology Medicines (NASDAQ:FIXX) shares made a new 52-week low of $1.91 on Wednesday. The stock was down 6.34% for the day.
    • Adverum Biotechnologies (NASDAQ:ADVM) stock drifted down 1.79% on Wednesday morning to hit a new 52-week low of $1.09.
    • Sientra (NASDAQ:SIEN) stock dropped to a yearly low on Wednesday of $1.62. Shares traded up 0.29%.
    • Surface Oncology (NASDAQ:SURF) stock dropped to a yearly low on Wednesday of $2.24. Shares traded down 3.43%.
    • Magenta Therapeutics (NASDAQ:MGTA) shares fell to $1.79 on Wednesday, setting a new 52-week low with a shift of down 5.03%.
    • Tabula Rasa HealthCare (NASDAQ:TRHC) shares were down 4.12% for the day, having made a 52-week low of $4.04.
    • GoHealth (NASDAQ:GOCO) stock drifted down 3.36% on Wednesday morning to hit a new 52-week low of $0.81.
    • Celcuity (NASDAQ:CELC) stock drifted down 5.45% on Wednesday morning to hit a new 52-week low of $6.94.
    • Mereo BioPharma Group (NASDAQ:MREO) shares made a new 52-week low of $0.83 on Wednesday. The stock was down 2.07% for the day.
    • SQZ Biotechnologies (NYSE:SQZ) shares made a new 52-week low of $3.48 on Wednesday. The stock was down 3.5% for the day.
    • Kirkland's (NASDAQ:KIRK) shares fell to $8.07 on Wednesday, setting a new 52-week low with a shift of down 2.86%.
    • Pulse Biosciences (NASDAQ:PLSE) shares set a new yearly low of $3.06 this morning. The stock was down 2.07% on the session.
    • Sesen Bio (NASDAQ:SESN) shares made a new 52-week low of $0.47 on Wednesday. The stock was down 2.25% for the day.
    • SCYNEXIS (NASDAQ:SCYX) shares were down 3.36% for the day, having made a 52-week low of $3.13.
    • Western Asset Mortgage (NYSE:WMC) shares moved up 0.33% on Wednesday to hit a new 52-week low of $1.49, drifting up 0.33%.
    • PLx Pharma (NASDAQ:PLXP) stock broke to a new 52-week low of $3.13 on Wednesday. Shares of the company traded down 3.93%.
    • Codiak BioSciences (NASDAQ:CDAK) stock achieved a new 52-week low on Wednesday morning, hitting $3.60 and moving up 0.79%.
    • icad (NASDAQ:ICAD) shares were down 2.72% for the day, having made a 52-week low of $3.19.
    • Seelos Therapeutics (NASDAQ:SEEL) shares fell to $0.72 on Wednesday, setting a new 52-week low with a shift of down 1.12%.
    • Bolt Biotherapeutics (NASDAQ:BOLT) stock broke to a new 52-week low of $2.07 on Wednesday. Shares of the company traded down 4.82%.
    • Esports Technologies (NASDAQ:EBET) shares made a new 52-week low of $5.01 on Wednesday. The stock was down 3.37% for the day.
    • Athenex (NASDAQ:ATNX) stock set a new 52-week low of $0.65 on Wednesday, moving down 4.42%.
    • Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock dropped to a yearly low on Wednesday of $1.60. Shares traded down 1.82%.
    • Helbiz (NASDAQ:HLBZ) shares set a new 52-week low of $1.87. The stock traded down 5.34%.
    • S&W Seed (NASDAQ:SANW) shares reached a new 52-week low of $1.67 on Wednesday morning, moving down 1.16%.
    • NewAge (NASDAQ:NBEV) shares set a new 52-week low of $0.43. The stock traded down 1.49%.
    • Corvus Pharmaceuticals (NASDAQ:CRVS) stock broke to a new 52-week low of $1.30 on Wednesday. Shares of the company traded down 2.19%.
    • Trinity Place Hldgs (AMEX:TPHS) stock hit $1.51 on Wednesday morning, setting a new 52-week low for a change of up 2.58%.
    • Marygold Companies (AMEX:MGLD) stock broke to a new 52-week low of $1.43 on Wednesday. Shares of the company traded down 2.37%.
    • ProQR Therapeutics (NASDAQ:PRQR) shares moved down 1.41% on Wednesday to hit a new 52-week low of $0.74, drifting down 1.41%.
    • ASLAN Pharma (NASDAQ:ASLN) stock dropped to a yearly low on Wednesday of $0.73. Shares traded down 2.59%.
    • mCloud Technologies (NASDAQ:MCLD) stock hit a yearly low of $2.75. The stock was down 4.84% for the day.
    • Cabaletta Bio (NASDAQ:CABA) stock drifted up 2.67% on Wednesday morning to hit a new 52-week low of $1.48.
    • Gulf (NASDAQ:GURE) stock hit $3.99 on Wednesday morning, setting a new 52-week low for a change of down 2.2%.
    • Intellicheck (NASDAQ:IDN) shares were down 2.05% for the day, having made a 52-week low of $2.13.
    • Cyclerion Therapeutics (NASDAQ:CYCN) stock broke to a new 52-week low of $0.83 on Wednesday. Shares of the company traded down 6.32%.
    • Oncorus (NASDAQ:ONCR) stock dropped to a yearly low on Wednesday of $1.30. Shares traded down 0.07%.
    • HyreCar (NASDAQ:HYRE) shares were down 8.24% for the day, having made a 52-week low of $1.54.
    • Boqii Holding (NYSE:BQ) shares were down 5.33% for the day, having made a 52-week low of $0.32.
    • Biocept (NASDAQ:BIOC) stock hit $1.71 on Wednesday morning, setting a new 52-week low for a change of up 0.28%.
    • Calyxt (NASDAQ:CLXT) shares hit a yearly low of $0.53. The stock was down 6.44% on the session.
    • Rail Vision (NASDAQ:RVSN) shares set a new 52-week low of $1.41. The stock traded down 0.34%.
    • Engine Gaming And Media (NASDAQ:GAME) shares made a new 52-week low of $1.35 on Wednesday. The stock was down 9.16% for the day.
    • Rubicon Technology (NASDAQ:RBCN) shares hit a yearly low of $8.58. The stock was down 0.63% on the session.
    • RenovoRx (NASDAQ:RNXT) shares set a new yearly low of $2.25 this morning. The stock was down 4.83% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a new 52-week low of $1.66. The stock was up 0.6% on the session.
    • LogicBio Therapeutics (NASDAQ:LOGC) stock hit a yearly low of $0.60. The stock was down 0.1% for the day.
    • Crown ElectroKinetics (NASDAQ:CRKN) stock broke to a new 52-week low of $1.24 on Wednesday. Shares of the company traded up 2.36%.
    • Kintara Therapeutics (NASDAQ:KTRA) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 3.79% for the day.
    • Kubient (NASDAQ:KBNT) stock drifted up 0.92% on Wednesday morning to hit a new 52-week low of $1.13.
    • ShiftPixy (NASDAQ:PIXY) shares hit a yearly low of $0.47. The stock was down 2.57% on the session.
    • Jupai Hldgs (NYSE:JP) stock hit a new 52-week low of $0.41. The stock was down 10.2% on the session.
    • FedNat Holding (NASDAQ:FNHC) stock hit a yearly low of $0.85. The stock was up 3.74% for the day.
    • Motorsport Games (NASDAQ:MSGM) shares were down 4.89% for the day, having made a 52-week low of $1.05.
    • Vallon Pharmaceuticals (NASDAQ:VLON) shares hit a yearly low of $1.17. The stock was down 3.2% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $ADVM
    $AFCG
    $ALLK

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    2/27/2026$115.00Outperform
    Evercore ISI
    Netflix Inc.
    $NFLX
    2/27/2026Neutral → Buy
    Arete
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Tyra Biosciences Inc.
    $TYRA
    2/24/2026Overweight
    Cantor Fitzgerald
    Praxis Precision Medicines Inc.
    $PRAX
    2/24/2026$500.00Outperform
    Wolfe Research
    Denali Therapeutics Inc.
    $DNLI
    2/24/2026Peer Perform
    Wolfe Research
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    Etsy Inc.
    $ETSY
    2/20/2026$72.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Elghandour Rami converted options into 164,548 shares and sold $10,243,267 worth of shares (89,916 units at $113.92), decreasing direct ownership by 55% to 276,051 units (SEC Form 4)

    4 - Arcellx, Inc. (0001786205) (Issuer)

    2/27/26 7:48:11 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Zoi Mike sold $86,951 worth of shares (24,024 units at $3.62) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    2/27/26 6:23:34 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Ekblom Anders

    4 - Mereo BioPharma Group plc (0001719714) (Issuer)

    2/27/26 4:30:16 PM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI resumed coverage on Netflix with a new price target

    Evercore ISI resumed coverage of Netflix with a rating of Outperform and set a new price target of $115.00

    2/27/26 8:31:30 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Netflix upgraded by Arete

    Arete upgraded Netflix from Neutral to Buy

    2/27/26 8:22:06 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    eHealth downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded eHealth from Buy to Hold and set a new price target of $2.00

    2/26/26 8:34:26 AM ET
    $EHTH
    Specialty Insurers
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bobbili Raja bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:42:27 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Large owner Abrams Capital Management, L.P. bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:37:36 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Abrams David C bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:36:32 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. The declarations have moved from monthly to quarterly to provide additional visibility on upcoming distributions. The funds will continue to pay monthly distributions. Municipal Funds: Certain Municipal Funds involved in upcoming mergers or reorganizations announced distributions separately. Distribution Month             Ex- & Record Date             Payable Date April             April 15, 2026             May 1, 2026 May             May 15, 2026             June 1, 2026 June             June 15, 2026            

    2/27/26 4:31:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

    Today, BlackRock Resources & Commodities Strategy Trust (NYSE:BCX), BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ), BlackRock Energy and Resources Trust (NYSE:BGR), BlackRock Enhanced International Dividend Trust (NYSE:BGY), BlackRock Health Sciences Trust (NYSE:BME), BlackRock Health Sciences Term Trust (NYSE:BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE:BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE:BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE:CII), BlackRock Science and Technology Trust (NYSE:BST), BlackRock Science and Technology Term Trust (NYSE:BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE:BTX), BlackRock Capital

    2/27/26 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

    Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA Clearance in 2014 Company Appoints Ramtin Agah, MD to the Additional Position of Executive Chairman to Support Continued Clinical Adoption and Commercial Growth MOUNTAIN VIEW, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced continued commercial progress, with

    2/27/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    SEC Filings

    View All

    SEC Form 144 filed by Arcellx Inc.

    144 - Arcellx, Inc. (0001786205) (Subject)

    2/27/26 7:31:42 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by Grupo Aval Acciones y Valores S.A.

    6-K - Grupo Aval Acciones Y Valores S.A. (0001504764) (Filer)

    2/27/26 5:04:28 PM ET
    $AVAL
    Commercial Banks
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Leadership Updates

    Live Leadership Updates

    View All

    RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

    Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA Clearance in 2014 Company Appoints Ramtin Agah, MD to the Additional Position of Executive Chairman to Support Continued Clinical Adoption and Commercial Growth MOUNTAIN VIEW, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced continued commercial progress, with

    2/27/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

    –Received Positive Pre-Investigational New Drug ("IND") Written Feedback from the U.S. Food and Drug Administration ("FDA")– –Clinical Advisory Board ("CAB") Includes Key Leaders across Neuropsychiatry, Anesthesiology, and Clinical Development– –Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC") Study in Treatment Resistant Depression ("TRD") in the Second Half of 2026– CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) ("Cyclerion" or "Company"), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced it has received positive written regulatory feedback and responses from the FDA on CYC-126

    2/17/26 7:00:00 AM ET
    $CYCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Financials

    Live finance-specific insights

    View All

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. The declarations have moved from monthly to quarterly to provide additional visibility on upcoming distributions. The funds will continue to pay monthly distributions. Municipal Funds: Certain Municipal Funds involved in upcoming mergers or reorganizations announced distributions separately. Distribution Month             Ex- & Record Date             Payable Date April             April 15, 2026             May 1, 2026 May             May 15, 2026             June 1, 2026 June             June 15, 2026            

    2/27/26 4:31:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

    Today, BlackRock Resources & Commodities Strategy Trust (NYSE:BCX), BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ), BlackRock Energy and Resources Trust (NYSE:BGR), BlackRock Enhanced International Dividend Trust (NYSE:BGY), BlackRock Health Sciences Trust (NYSE:BME), BlackRock Health Sciences Term Trust (NYSE:BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE:BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE:BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE:CII), BlackRock Science and Technology Trust (NYSE:BST), BlackRock Science and Technology Term Trust (NYSE:BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE:BTX), BlackRock Capital

    2/27/26 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Rocket Companies Announces Fourth Quarter and Full Year 2025 Results

    Announced three-year strategic alliance with Compass International Holdings to expand housing inventory and create a more streamlined and affordable home buying and selling experience for American families.Appointed Rocket Companies' CFO Brian Brown to the role of President, who will continue as CFO and Treasurer, effective February 26, 2026.Generated Q4'25 total revenue, net of $2.69 billion and adjusted revenue of $2.44 billion. Adjusted revenue came in above the high end of our guidance range.Reported Q4'25 GAAP net income of $68 million and adjusted net income of $316 million.Delivered Q4'25 adjusted EBITDA of $592 million.DETROIT, Feb. 26, 2026 /PRNewswire/ -- Rocket Companies, Inc. (NY

    2/26/26 4:05:00 PM ET
    $RKT
    Finance: Consumer Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Rocket Companies Inc. on Jun 21

    Recently, there has been a series of insider purchases at Rocket Companies Inc. by Director Rizik Matthew. On 2024-06-21, Director Rizik Matthew made a purchase of $8,648 worth of shares, acquiring 622 units at a price of $13.90. This transaction increased his direct ownership by 0.09% to 706,108 units, as reported in SEC Form 4. This purchase indicates confidence from an insider in the company's prospects. Building up to this latest purchase, Rizik Matthew had also bought shares in the previous month. On 2024-05-31, he acquired $4,375 worth of shares (317 units at $13.80), increasing his direct ownership by 0.05% to 702,497 units. Following this, he made purchases on 2024-06-05, 2024-06-07

    6/22/24 7:57:56 PM ET
    $RKT
    Finance: Consumer Services
    Finance

    Insider Analysis: Purchase at Rocket Companies Inc. on Jun 7

    Rizik Matthew, a prominent figure at Rocket Companies Inc., has been steadily increasing his direct ownership in the company through a series of insider purchases over the past couple of months. The most recent purchase, which took place on June 7, 2024, saw Rizik Matthew acquiring $8,630 worth of shares, equivalent to 602 units at $14.34 per share. This transaction resulted in a marginal increase in his direct ownership by 0.09%, bringing his total direct ownership to 703,727 units as reported in the SEC Form 4. When we examine the pattern of Rizik Matthew's insider purchases leading up to the latest transaction, we can observe a consistent trend of incremental increases in direct ownershi

    6/10/24 12:42:26 AM ET
    $RKT
    Finance: Consumer Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Neuberger Berman Municipal Fund Inc.

    SC 13D/A - NEUBERGER BERMAN MUNICIPAL FUND INC. (0001178839) (Subject)

    12/13/24 4:42:44 PM ET
    $NBH
    Finance/Investors Services
    Finance